Cargando…

A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study

INTRODUCTION: The aim of the study was to analyse genetic architecture of RA by utilizing multiparametric statistical methods such as linear discriminant analysis (LDA) and redundancy analysis (RDA). METHODS: A total of 1393 volunteers, 499 patients with RA and 894 healthy controls were included in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vernerova, Lucia, Spoutil, Frantisek, Vlcek, Miroslav, Krskova, Katarina, Penesova, Adela, Meskova, Milada, Marko, Andrea, Raslova, Katarina, Vohnout, Branislav, Rovensky, Jozef, Killinger, Zdenko, Jochmanova, Ivana, Lazurova, Ivica, Steiner, Guenter, Smolen, Josef, Imrich, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836711/
https://www.ncbi.nlm.nih.gov/pubmed/27092776
http://dx.doi.org/10.1371/journal.pone.0153316
_version_ 1782427770090946560
author Vernerova, Lucia
Spoutil, Frantisek
Vlcek, Miroslav
Krskova, Katarina
Penesova, Adela
Meskova, Milada
Marko, Andrea
Raslova, Katarina
Vohnout, Branislav
Rovensky, Jozef
Killinger, Zdenko
Jochmanova, Ivana
Lazurova, Ivica
Steiner, Guenter
Smolen, Josef
Imrich, Richard
author_facet Vernerova, Lucia
Spoutil, Frantisek
Vlcek, Miroslav
Krskova, Katarina
Penesova, Adela
Meskova, Milada
Marko, Andrea
Raslova, Katarina
Vohnout, Branislav
Rovensky, Jozef
Killinger, Zdenko
Jochmanova, Ivana
Lazurova, Ivica
Steiner, Guenter
Smolen, Josef
Imrich, Richard
author_sort Vernerova, Lucia
collection PubMed
description INTRODUCTION: The aim of the study was to analyse genetic architecture of RA by utilizing multiparametric statistical methods such as linear discriminant analysis (LDA) and redundancy analysis (RDA). METHODS: A total of 1393 volunteers, 499 patients with RA and 894 healthy controls were included in the study. The presence of shared epitope (SE) in HLA-DRB1 and 11 SNPs (PTPN22 C/T (rs2476601), STAT4 G/T (rs7574865), CTLA4 A/G (rs3087243), TRAF1/C5 A/G (rs3761847), IRF5 T/C (rs10488631), TNFAIP3 C/T (rs5029937), AFF3 A/T (rs11676922), PADI4 C/T (rs2240340), CD28 T/C (rs1980422), CSK G/A (rs34933034) and FCGR3A A/C (rs396991), rheumatoid factor (RF), anti–citrullinated protein antibodies (ACPA) and clinical status was analysed using the LDA and RDA. RESULTS: HLA-DRB1, PTPN22, STAT4, IRF5 and PADI4 significantly discriminated between RA patients and healthy controls in LDA. The correlation between RA diagnosis and the explanatory variables in the model was 0.328 (Trace = 0.107; F = 13.715; P = 0.0002). The risk variants of IRF5 and CD28 genes were found to be common determinants for seropositivity in RDA, while positivity of RF alone was associated with the CTLA4 risk variant in heterozygous form. The correlation between serologic status and genetic determinants on the 1st ordinal axis was 0.468, and 0.145 on the 2nd one (Trace = 0.179; F = 6.135; P = 0.001). The risk alleles in AFF3 gene together with the presence of ACPA were associated with higher clinical severity of RA. CONCLUSIONS: The association among multiple risk variants related to T cell receptor signalling with seropositivity may play an important role in distinct clinical phenotypes of RA. Our study demonstrates that multiparametric analyses represent a powerful tool for investigation of mutual relationships of potential risk factors in complex diseases such as RA.
format Online
Article
Text
id pubmed-4836711
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48367112016-04-29 A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study Vernerova, Lucia Spoutil, Frantisek Vlcek, Miroslav Krskova, Katarina Penesova, Adela Meskova, Milada Marko, Andrea Raslova, Katarina Vohnout, Branislav Rovensky, Jozef Killinger, Zdenko Jochmanova, Ivana Lazurova, Ivica Steiner, Guenter Smolen, Josef Imrich, Richard PLoS One Research Article INTRODUCTION: The aim of the study was to analyse genetic architecture of RA by utilizing multiparametric statistical methods such as linear discriminant analysis (LDA) and redundancy analysis (RDA). METHODS: A total of 1393 volunteers, 499 patients with RA and 894 healthy controls were included in the study. The presence of shared epitope (SE) in HLA-DRB1 and 11 SNPs (PTPN22 C/T (rs2476601), STAT4 G/T (rs7574865), CTLA4 A/G (rs3087243), TRAF1/C5 A/G (rs3761847), IRF5 T/C (rs10488631), TNFAIP3 C/T (rs5029937), AFF3 A/T (rs11676922), PADI4 C/T (rs2240340), CD28 T/C (rs1980422), CSK G/A (rs34933034) and FCGR3A A/C (rs396991), rheumatoid factor (RF), anti–citrullinated protein antibodies (ACPA) and clinical status was analysed using the LDA and RDA. RESULTS: HLA-DRB1, PTPN22, STAT4, IRF5 and PADI4 significantly discriminated between RA patients and healthy controls in LDA. The correlation between RA diagnosis and the explanatory variables in the model was 0.328 (Trace = 0.107; F = 13.715; P = 0.0002). The risk variants of IRF5 and CD28 genes were found to be common determinants for seropositivity in RDA, while positivity of RF alone was associated with the CTLA4 risk variant in heterozygous form. The correlation between serologic status and genetic determinants on the 1st ordinal axis was 0.468, and 0.145 on the 2nd one (Trace = 0.179; F = 6.135; P = 0.001). The risk alleles in AFF3 gene together with the presence of ACPA were associated with higher clinical severity of RA. CONCLUSIONS: The association among multiple risk variants related to T cell receptor signalling with seropositivity may play an important role in distinct clinical phenotypes of RA. Our study demonstrates that multiparametric analyses represent a powerful tool for investigation of mutual relationships of potential risk factors in complex diseases such as RA. Public Library of Science 2016-04-19 /pmc/articles/PMC4836711/ /pubmed/27092776 http://dx.doi.org/10.1371/journal.pone.0153316 Text en © 2016 Vernerova et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Vernerova, Lucia
Spoutil, Frantisek
Vlcek, Miroslav
Krskova, Katarina
Penesova, Adela
Meskova, Milada
Marko, Andrea
Raslova, Katarina
Vohnout, Branislav
Rovensky, Jozef
Killinger, Zdenko
Jochmanova, Ivana
Lazurova, Ivica
Steiner, Guenter
Smolen, Josef
Imrich, Richard
A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study
title A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study
title_full A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study
title_fullStr A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study
title_full_unstemmed A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study
title_short A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study
title_sort combination of cd28 (rs1980422) and irf5 (rs10488631) polymorphisms is associated with seropositivity in rheumatoid arthritis: a case control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836711/
https://www.ncbi.nlm.nih.gov/pubmed/27092776
http://dx.doi.org/10.1371/journal.pone.0153316
work_keys_str_mv AT vernerovalucia acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT spoutilfrantisek acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT vlcekmiroslav acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT krskovakatarina acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT penesovaadela acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT meskovamilada acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT markoandrea acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT raslovakatarina acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT vohnoutbranislav acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT rovenskyjozef acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT killingerzdenko acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT jochmanovaivana acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT lazurovaivica acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT steinerguenter acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT smolenjosef acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT imrichrichard acombinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT vernerovalucia combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT spoutilfrantisek combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT vlcekmiroslav combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT krskovakatarina combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT penesovaadela combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT meskovamilada combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT markoandrea combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT raslovakatarina combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT vohnoutbranislav combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT rovenskyjozef combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT killingerzdenko combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT jochmanovaivana combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT lazurovaivica combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT steinerguenter combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT smolenjosef combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy
AT imrichrichard combinationofcd28rs1980422andirf5rs10488631polymorphismsisassociatedwithseropositivityinrheumatoidarthritisacasecontrolstudy